increas
number
virolog
laboratori
utilis
hous
real
time
pcr
assay
frontlin
diagnost
test
number
test
offer
increas
natur
progress
rationalis
servic
via
multiplex
sinc
introduc
larg
number
qualit
quantit
multiplex
real
time
pcr
assay
routin
test
servic
paper
describ
develop
multiplex
assay
problem
encount
result
benefit
routin
servic
advent
pcr
transform
util
viru
diagnost
laboratori
compar
tradit
method
led
mani
benefit
includ
improv
patient
manag
increas
ascertain
previous
underdiagnos
undetect
virus
advent
real
time
pcr
technolog
improv
upon
alreadi
signific
benefit
comparison
tradit
gelbas
pcr
assay
real
time
pcr
offer
similar
improv
sensit
specif
rapid
format
turn
around
time
sampl
receipt
result
h
sinc
real
time
pcr
reaction
perform
close
system
gel
analysi
need
risk
contamin
substanti
reduc
also
reduc
requir
stringent
laboratori
structur
increas
number
commerci
avail
real
time
pcr
chemistri
platform
led
signific
reduct
overal
cost
sinc
introduc
number
qualit
quantit
real
time
pcr
assay
routin
test
servic
includ
assay
detect
influenza
b
c
human
metapneumoviru
respiratori
syncyti
virus
rsv
b
rhinoviru
parainfluenza
virus
coronavirus
mycoplasma
pneumonia
pneumocysti
jiroveci
varicella
zoster
viru
vzv
herp
simplex
viru
hsv
cytomegaloviru
cmv
epstein
barr
viru
ebv
noroviru
adenoviru
rotaviru
astroviru
sapoviru
erythroviru
mump
measl
rubella
chlamydia
trachomati
nesseria
gonnorhoea
treponema
pallidum
hbv
hcv
hcv
genotyp
hev
enteroviru
parechoviru
develop
strategi
enabl
increas
sampl
throughput
maintain
even
reduc
turn
around
time
develop
multiplex
number
separ
real
time
pcr
assay
one
test
remain
effect
way
improv
rapid
cost
eas
use
throughput
pcrbase
diagnost
servic
exampl
frontlin
respiratori
servic
consist
five
real
time
pcr
assay
togeth
allow
detect
eight
commonli
encount
pathogen
tabl
multiplex
respiratori
servic
still
consist
five
separ
assay
detect
differ
viral
bacteri
pathogen
appli
principl
nonrespiratori
diagnost
servic
case
multiplex
assay
design
test
certain
sampl
type
repres
differ
diseas
syndrom
work
reduc
number
test
carri
tabl
describ
develop
multiplex
assay
problem
encount
result
benefit
sinc
compon
propos
multiplex
initi
avail
singleplex
assay
initi
experi
carri
ensur
addit
extra
primer
probe
line
repres
well
addit
target
previous
includ
laboratori
repertoir
result
loss
test
perform
addit
primer
probe
result
unpredict
reduc
sensit
format
nonspecif
product
propos
multiplex
assay
compar
singleplex
use
endpoint
detect
limit
experi
specif
panel
panel
clinic
sampl
posit
neg
factor
robust
reproduc
relev
linear
quantit
accuraci
also
assess
test
would
deem
accept
shown
ident
superior
perform
individu
test
failur
stage
requir
experi
use
alter
concentr
primer
probe
chang
result
accept
improv
test
perform
test
discard
test
would
continu
use
singl
assay
new
test
could
identifi
literatur
prove
simpler
multiplex
candid
assay
would
rigor
assess
singleplex
format
assess
part
multiplex
assay
multiplex
assay
unlik
encount
mix
infect
csf
need
assess
perform
presenc
target
necessari
standard
commerci
pcr
kit
use
howev
mix
infect
like
common
sampl
intern
control
amplifi
everi
sampl
import
studi
relev
competit
stronger
target
preferenti
amplifi
use
avail
pcr
reagent
reduc
sensit
part
multiplex
alway
target
preferenti
amplifi
result
fals
neg
result
quantit
assay
may
result
incorrect
viral
load
commerci
pcr
kit
design
specif
multiplex
reliabl
pathogen
present
particularli
concentr
target
significantli
differ
test
characterist
assess
use
chessboard
techniqu
design
provid
larg
number
well
contain
known
concentr
two
pcr
target
differ
ratio
tabl
well
test
multiplex
pcr
result
compar
perform
dilut
seri
target
experi
determin
whether
competit
like
issu
also
measur
ratio
target
competit
expect
care
optimis
pcr
reagent
remov
problem
exampl
limit
concentr
tabl
chessboard
procedur
use
determin
well
multiplex
test
perform
sampl
contain
target
dilut
seri
extract
nucleic
acid
pathogen
pathogen
made
use
microtitr
plate
volum
dilut
pathogen
ad
column
exampl
dilut
pathogen
label
present
first
well
column
subsequ
equal
volum
dilut
pathogen
ad
row
exampl
dilut
pathogen
label
present
first
column
well
contain
differ
concentr
pathogen
use
assess
multiplex
pcr
primer
use
pcr
assay
preferenti
amplifi
prevent
strong
posit
sampl
use
avail
pcr
reagent
howev
must
carri
without
reduc
sensit
assay
assay
use
intern
control
low
concentr
intern
control
includ
assay
ensur
competit
kept
minimum
flipsid
strong
posit
sampl
compet
intern
control
lead
sampl
wrongli
label
inhibit
lead
doubt
whether
result
given
accur
recent
year
commerci
compani
attempt
rectifi
problem
via
use
pcr
kit
specif
develop
multiplex
pcr
exampl
use
qiagen
multiplex
kit
transplant
screen
simultan
detect
quantifi
adenoviru
cmv
ebv
wwwqiagencom
kit
design
specif
plex
real
time
pcr
variou
mechan
shown
prevent
test
interactioncompetit
therefor
allow
simultan
detect
accur
quantit
take
place
use
kit
allow
us
develop
singl
set
five
standard
contain
known
concentr
three
virus
adenoviru
cmv
ebv
five
standard
provid
linear
reproduc
standard
curv
three
pathogen
also
use
kit
std
screen
confirm
assay
use
detect
c
trachomati
nessieria
gonnorhoea
intern
control
singl
tube
prefer
dye
triplex
assay
fam
vic
dye
combin
work
assay
platform
commonli
use
research
dye
chosen
excit
emiss
wavelength
differ
enough
allow
accur
detect
reduc
risk
crosstalk
crosstalk
fluoresc
increas
associ
one
dye
spill
anoth
channel
use
detect
anoth
dye
lead
two
posit
result
one
real
one
sometim
strong
fam
signal
also
detect
vic
channel
result
fals
posit
result
pcr
platform
also
confus
larg
increas
victamra
signal
increas
background
calibr
dye
rox
subsequ
platform
reduc
fluoresc
level
dye
detect
well
occas
result
fals
neg
trace
strang
trace
case
crosstalk
elimin
appropri
test
optimis
eg
reduc
increas
amount
dyeprob
present
without
loss
test
sensit
pcr
platform
recalibr
howev
develop
plex
assay
choic
dye
fourth
assay
limit
depend
upon
pcr
platform
whether
pcr
kit
use
rox
refer
dye
result
research
often
use
dye
similar
excit
emiss
spectra
fam
vic
increas
risk
crosstalk
two
current
assay
conjunct
nonnoroviru
gastroenter
multiplex
utilis
four
differ
floresc
dye
laboratori
test
carri
either
rotorgen
pcr
platform
abi
tamra
bidopi
ned
recommend
dye
wherea
texa
red
rox
suggest
rotorgen
howev
despit
guidanc
signific
crosstalk
encount
exampl
use
tamra
biodopi
posit
trace
found
dye
channel
fig
posit
texa
red
trace
rotorgen
found
appear
channel
care
optimis
could
rectifi
issu
machin
calibr
fault
elimin
use
rox
dye
platform
fig
note
use
rox
probe
dye
recommend
abi
pcr
platform
commonli
use
refer
dye
howev
function
switch
found
problem
use
fourth
dye
qualit
test
also
note
pcr
kit
come
rox
alreadi
ad
therefor
may
use
situat
use
multiplex
pcr
result
sever
posit
outcom
laboratori
servic
exampl
abil
add
target
without
increas
number
assay
need
fig
abi
trace
show
appear
crosstalk
channel
shown
arrow
appear
use
tamrabidopi
fourth
dye
unarrow
trace
posit
control
diagram
b
show
crosstalk
gone
rox
use
fourth
dye
remain
trace
posit
control
set
allow
inclus
pathogen
previous
test
includ
new
discoveri
eg
human
metapneumoviru
coronaviru
inclus
parechoviru
test
increas
detect
rate
patient
enteroviru
like
ill
wherea
inclus
human
metapneumoviru
influenza
c
parainlfuenza
coronavirus
lead
increas
overal
viral
detect
rate
respiratori
sampl
improv
posit
outcom
clinic
manag
infect
control
public
health
sinc
test
like
provid
relev
diagnost
result
associ
increas
cost
multiplex
fewer
test
carri
less
reagent
particular
pcr
mastermixth
expens
compon
pcr
test
extract
cost
requir
tabl
signific
cost
save
may
also
achiev
due
fact
servic
requir
less
staff
hand
time
multiplex
sampl
typediseas
syndrom
simplifi
routin
servic
reduct
sampl
turn
around
time
achiev
reduc
amount
separ
test
need
carri
ensur
sampl
test
within
work
day
futur
simplif
test
procedur
also
aid
develop
autom
test
system
turn
make
servic
less
error
prone
rapid
test
select
also
becom
straightforward
base
diseas
syndrom
rather
pathogen
type
mirror
multiplex
test
design
littl
senior
staff
input
requir
test
select
report
result
streamlin
sinc
relev
result
avail
time
rather
sequenti
consequ
virologist
abl
advis
base
complet
pictur
combin
quicker
turn
around
time
lead
improv
patient
manag
disadvantag
associ
adopt
system
firstli
multiplex
less
abl
provid
singl
pathogen
test
consequ
sampl
may
get
addit
test
result
initi
request
lead
small
extra
unnecessari
cost
may
also
provid
unexpect
result
may
caus
interpret
difficulti
exampl
test
bal
cmv
result
addit
test
adenoviru
ebv
number
case
detect
ebv
high
viral
load
unclear
role
viru
clinic
pictur
laboratori
use
pcr
kit
design
multiplex
may
fail
detect
mix
infect
increas
number
virolog
laboratori
utilis
hous
real
time
pcr
assay
frontlin
diagnost
test
number
test
offer
increas
natur
progress
rationalis
servic
via
multiplex
process
present
limit
number
fluoresc
dye
avail
probe
manufactur
number
channel
avail
detect
pcr
platform
limit
lack
commerci
kit
specif
design
multiplex
pcr
factor
address
laboratori
abl
multiplex
much
simpli
bring
signific
servic
benefit
